These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9371230)

  • 21. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
    Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of types XV and XIX collagen precedes basement membrane invasion in ductal carcinoma of the female breast.
    Amenta PS; Hadad S; Lee MT; Barnard N; Li D; Myers JC
    J Pathol; 2003 Mar; 199(3):298-308. PubMed ID: 12579531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
    Jimenez RE; Wallis T; Tabasczka P; Visscher DW
    Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
    Buerger H; Otterbach F; Simon R; Poremba C; Diallo R; Decker T; Riethdorf L; Brinkschmidt C; Dockhorn-Dworniczak B; Boecker W
    J Pathol; 1999 Mar; 187(4):396-402. PubMed ID: 10398097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK; Tjan S; Parkes RK; O'Malley FP
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A SAGE (serial analysis of gene expression) view of breast tumor progression.
    Porter DA; Krop IE; Nasser S; Sgroi D; Kaelin CM; Marks JR; Riggins G; Polyak K
    Cancer Res; 2001 Aug; 61(15):5697-702. PubMed ID: 11479200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells.
    Soini Y; Vakkala M; Kahlos K; Pääkkö P; Kinnula V
    J Pathol; 2001 Sep; 195(2):156-62. PubMed ID: 11592093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
    Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma.
    Gatalica Z; Lele SM; Rampy BA; Norris BA
    Cancer; 2000 Mar; 88(6):1378-83. PubMed ID: 10717620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma.
    Zhu XL; Hartwick W; Rohan T; Kandel R
    Mod Pathol; 1998 Nov; 11(11):1082-8. PubMed ID: 9831206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas.
    Lebeau A; Nerlich AG; Sauer U; Lichtinghagen R; Löhrs U
    Anticancer Res; 1999; 19(5B):4257-64. PubMed ID: 10628384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer.
    Dhar S; Bhargava R; Yunes M; Li B; Goyal J; Naber SP; Wazer DE; Band V
    Clin Cancer Res; 2001 Nov; 7(11):3393-8. PubMed ID: 11705853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland.
    Hombach-Klonisch S; Buchmann J; Sarun S; Fischer B; Klonisch T
    Cancer; 2000 Dec; 89(11):2161-8. PubMed ID: 11147585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    Lee AH; Dublin EA; Bobrow LG; Poulsom R
    J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor alpha (ESR1) mutant A908G is not a common feature in benign and malignant proliferations of the breast.
    Tebbit CL; Bentley RC; Olson JA; Marks JR
    Genes Chromosomes Cancer; 2004 May; 40(1):51-4. PubMed ID: 15034868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
    González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
    Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.